| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myofibroblasts | 15 | 2024 | 51 | 4.830 |
Why?
|
| Transforming Growth Factor beta | 15 | 2024 | 347 | 2.180 |
Why?
|
| Cell Differentiation | 19 | 2024 | 1621 | 2.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 16 | 2016 | 111 | 2.120 |
Why?
|
| RGS Proteins | 10 | 2013 | 19 | 2.070 |
Why?
|
| Signal Transduction | 40 | 2024 | 3502 | 1.810 |
Why?
|
| Lung | 15 | 2024 | 1366 | 1.570 |
Why?
|
| Pulmonary Fibrosis | 8 | 2019 | 152 | 1.480 |
Why?
|
| Muscle, Smooth, Vascular | 12 | 2007 | 232 | 1.410 |
Why?
|
| GTP-Binding Proteins | 10 | 2013 | 147 | 1.280 |
Why?
|
| Fibroblasts | 10 | 2023 | 756 | 1.240 |
Why?
|
| Serum Response Factor | 9 | 2013 | 42 | 1.120 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2023 | 210 | 0.950 |
Why?
|
| Muscle, Smooth | 9 | 2015 | 300 | 0.930 |
Why?
|
| Actins | 11 | 2018 | 467 | 0.920 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 2 | 2024 | 6 | 0.900 |
Why?
|
| GTPase-Activating Proteins | 7 | 2013 | 68 | 0.870 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 2019 | 88 | 0.840 |
Why?
|
| Phosphorylation | 22 | 2024 | 1133 | 0.820 |
Why?
|
| Cells, Cultured | 30 | 2024 | 2850 | 0.800 |
Why?
|
| Adenosine Triphosphate | 6 | 2008 | 319 | 0.720 |
Why?
|
| Animals | 72 | 2023 | 28155 | 0.700 |
Why?
|
| Endothelin-1 | 5 | 2007 | 41 | 0.690 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2023 | 86 | 0.690 |
Why?
|
| Gene Expression Regulation | 11 | 2016 | 1985 | 0.680 |
Why?
|
| Cytoskeleton | 6 | 2016 | 198 | 0.650 |
Why?
|
| Bleomycin | 7 | 2019 | 99 | 0.650 |
Why?
|
| Fibrosis | 2 | 2019 | 230 | 0.620 |
Why?
|
| Trans-Activators | 5 | 2015 | 439 | 0.560 |
Why?
|
| beta Catenin | 4 | 2010 | 265 | 0.540 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 169 | 0.540 |
Why?
|
| Smad Proteins | 4 | 2013 | 42 | 0.530 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 304 | 0.510 |
Why?
|
| Stress Fibers | 3 | 2018 | 23 | 0.480 |
Why?
|
| Microtubules | 2 | 2014 | 134 | 0.470 |
Why?
|
| Cyclic AMP | 9 | 2013 | 276 | 0.470 |
Why?
|
| Enzyme Inhibitors | 10 | 2018 | 641 | 0.460 |
Why?
|
| Transcription, Genetic | 5 | 2008 | 1117 | 0.460 |
Why?
|
| Collagen | 6 | 2019 | 304 | 0.460 |
Why?
|
| Ouabain | 5 | 2016 | 24 | 0.450 |
Why?
|
| Smad2 Protein | 3 | 2024 | 24 | 0.430 |
Why?
|
| Enzyme Activation | 18 | 2016 | 674 | 0.430 |
Why?
|
| Rats, Inbred WKY | 12 | 2008 | 31 | 0.430 |
Why?
|
| Noscapine | 1 | 2014 | 1 | 0.420 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2014 | 4 | 0.420 |
Why?
|
| Antitussive Agents | 1 | 2014 | 3 | 0.420 |
Why?
|
| Rats | 26 | 2009 | 4072 | 0.410 |
Why?
|
| Adrenomedullin | 1 | 2013 | 5 | 0.400 |
Why?
|
| Vasoconstrictor Agents | 2 | 2007 | 67 | 0.390 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 90 | 0.390 |
Why?
|
| Cell Movement | 4 | 2013 | 809 | 0.380 |
Why?
|
| Sodium | 7 | 2015 | 329 | 0.380 |
Why?
|
| Humans | 62 | 2024 | 93515 | 0.380 |
Why?
|
| Th2 Cells | 1 | 2013 | 149 | 0.380 |
Why?
|
| T-Lymphocytes | 5 | 2013 | 1275 | 0.370 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2011 | 134 | 0.370 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 185 | 0.360 |
Why?
|
| Glycogen Synthase Kinase 3 | 4 | 2011 | 69 | 0.350 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2018 | 123 | 0.340 |
Why?
|
| Gene Expression | 8 | 2016 | 1301 | 0.340 |
Why?
|
| Down-Regulation | 5 | 2016 | 524 | 0.330 |
Why?
|
| Smad3 Protein | 3 | 2024 | 25 | 0.330 |
Why?
|
| Cell Division | 5 | 2008 | 693 | 0.320 |
Why?
|
| Cardiac Glycosides | 2 | 2022 | 5 | 0.310 |
Why?
|
| Angiotensin II | 4 | 1998 | 94 | 0.310 |
Why?
|
| Luciferases | 5 | 2014 | 129 | 0.300 |
Why?
|
| Chlorides | 3 | 2023 | 101 | 0.290 |
Why?
|
| Blotting, Western | 9 | 2013 | 784 | 0.290 |
Why?
|
| Cell Line | 13 | 2015 | 2464 | 0.280 |
Why?
|
| Mice | 18 | 2023 | 12269 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2009 | 740 | 0.280 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2019 | 51 | 0.270 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 1234 | 0.270 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2005 | 16 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 366 | 0.270 |
Why?
|
| Phosphoglycerate Dehydrogenase | 2 | 2018 | 8 | 0.270 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2007 | 5 | 0.260 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2007 | 6 | 0.260 |
Why?
|
| Inflammation | 1 | 2013 | 1050 | 0.260 |
Why?
|
| Trachea | 4 | 2011 | 245 | 0.260 |
Why?
|
| Epoprostenol | 1 | 2007 | 46 | 0.260 |
Why?
|
| Apoptosis | 10 | 2013 | 1721 | 0.260 |
Why?
|
| CHO Cells | 7 | 2009 | 187 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2007 | 66 | 0.250 |
Why?
|
| Cardiotonic Agents | 2 | 2019 | 88 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 8 | 2023 | 3435 | 0.250 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 4 | 2013 | 11 | 0.240 |
Why?
|
| Cricetinae | 7 | 2009 | 532 | 0.240 |
Why?
|
| RNA, Small Interfering | 2 | 2023 | 555 | 0.240 |
Why?
|
| Genes, Reporter | 5 | 2011 | 275 | 0.240 |
Why?
|
| Isoproterenol | 2 | 2007 | 57 | 0.240 |
Why?
|
| Phospholipases A | 3 | 2005 | 45 | 0.230 |
Why?
|
| Shock, Septic | 1 | 2007 | 124 | 0.230 |
Why?
|
| Calcium | 9 | 2007 | 1176 | 0.230 |
Why?
|
| Receptors, Angiotensin | 2 | 1995 | 11 | 0.230 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 301 | 0.230 |
Why?
|
| Proteins | 7 | 2003 | 803 | 0.220 |
Why?
|
| Aorta | 6 | 2008 | 273 | 0.220 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 7 | 1999 | 85 | 0.220 |
Why?
|
| Asthma | 5 | 2011 | 1039 | 0.220 |
Why?
|
| Proteasome Inhibitors | 1 | 2004 | 52 | 0.220 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 71 | 0.210 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 2495 | 0.210 |
Why?
|
| Serine | 3 | 2018 | 105 | 0.210 |
Why?
|
| Transfection | 6 | 2015 | 880 | 0.210 |
Why?
|
| Anoctamin-1 | 1 | 2023 | 4 | 0.210 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 12 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 660 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2003 | 216 | 0.200 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 163 | 0.200 |
Why?
|
| Focal Adhesions | 2 | 2016 | 66 | 0.200 |
Why?
|
| Steroids | 2 | 2019 | 168 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2004 | 392 | 0.200 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 3 | 2010 | 17 | 0.200 |
Why?
|
| DNA, Complementary | 4 | 2008 | 384 | 0.200 |
Why?
|
| Potassium | 5 | 2015 | 232 | 0.190 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 14 | 0.190 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 73 | 0.190 |
Why?
|
| NF-kappa B | 5 | 2003 | 408 | 0.190 |
Why?
|
| Prion Diseases | 1 | 2022 | 31 | 0.190 |
Why?
|
| Extracellular Matrix | 2 | 2016 | 256 | 0.190 |
Why?
|
| Prions | 1 | 2022 | 52 | 0.190 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 41 | 0.190 |
Why?
|
| Protein Kinase C | 11 | 2011 | 261 | 0.190 |
Why?
|
| Protein Binding | 8 | 2010 | 1534 | 0.180 |
Why?
|
| Membrane Proteins | 7 | 2011 | 1264 | 0.180 |
Why?
|
| I-kappa B Proteins | 2 | 2003 | 47 | 0.180 |
Why?
|
| Bronchi | 1 | 2003 | 225 | 0.180 |
Why?
|
| Immunologic Memory | 1 | 2023 | 184 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2013 | 134 | 0.170 |
Why?
|
| Receptors, Endothelin | 1 | 2001 | 12 | 0.170 |
Why?
|
| Neoplasms | 2 | 2014 | 3169 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2023 | 287 | 0.170 |
Why?
|
| Binding Sites | 4 | 2015 | 1133 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 1 | 2001 | 119 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 123 | 0.170 |
Why?
|
| Ion Transport | 2 | 2019 | 84 | 0.150 |
Why?
|
| Oligopeptides | 3 | 2011 | 191 | 0.150 |
Why?
|
| Glutaminase | 1 | 2019 | 14 | 0.150 |
Why?
|
| Tannins | 1 | 2019 | 1 | 0.150 |
Why?
|
| Arachidonic Acid | 2 | 1998 | 62 | 0.150 |
Why?
|
| Muscle Contraction | 5 | 2011 | 256 | 0.150 |
Why?
|
| Hypertension | 8 | 2014 | 757 | 0.150 |
Why?
|
| Mast Cells | 2 | 1990 | 96 | 0.150 |
Why?
|
| Tyrosine | 2 | 1998 | 131 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2009 | 66 | 0.150 |
Why?
|
| Cytoskeletal Proteins | 2 | 2011 | 223 | 0.150 |
Why?
|
| Glutamine | 1 | 2019 | 93 | 0.150 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 136 | 0.150 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 44 | 0.140 |
Why?
|
| Cricetulus | 2 | 2009 | 122 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 729 | 0.140 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1998 | 52 | 0.140 |
Why?
|
| Phenotype | 6 | 2018 | 2544 | 0.140 |
Why?
|
| Oncogene Proteins | 1 | 2019 | 65 | 0.140 |
Why?
|
| DNA | 5 | 2016 | 1265 | 0.140 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 4 | 2014 | 22 | 0.140 |
Why?
|
| Kidney | 5 | 2005 | 1111 | 0.140 |
Why?
|
| Transcription Factors | 4 | 2010 | 1691 | 0.140 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 18 | 0.140 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2018 | 57 | 0.140 |
Why?
|
| Carrier Proteins | 5 | 2004 | 663 | 0.140 |
Why?
|
| Airway Remodeling | 1 | 2018 | 10 | 0.140 |
Why?
|
| Flow Cytometry | 6 | 2013 | 712 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2019 | 2121 | 0.140 |
Why?
|
| Kidney Tubules | 1 | 1998 | 91 | 0.140 |
Why?
|
| Transduction, Genetic | 2 | 2011 | 160 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2018 | 56 | 0.130 |
Why?
|
| Adenoviridae | 2 | 2011 | 340 | 0.130 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2016 | 5 | 0.130 |
Why?
|
| Sirtuin 3 | 1 | 2016 | 36 | 0.120 |
Why?
|
| Digoxin | 1 | 2016 | 21 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 502 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 200 | 0.120 |
Why?
|
| HeLa Cells | 4 | 2009 | 517 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 1998 | 506 | 0.120 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 149 | 0.110 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Microfilament Proteins | 2 | 2011 | 209 | 0.110 |
Why?
|
| Hydrozoa | 1 | 2015 | 3 | 0.110 |
Why?
|
| Sodium Chloride Symporters | 1 | 2014 | 14 | 0.110 |
Why?
|
| Aquatic Organisms | 1 | 2015 | 19 | 0.110 |
Why?
|
| Kidney Cortex | 1 | 1994 | 30 | 0.110 |
Why?
|
| Erythrocytes | 6 | 1991 | 239 | 0.110 |
Why?
|
| Microvilli | 1 | 1994 | 44 | 0.110 |
Why?
|
| Pyridines | 2 | 2013 | 303 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2010 | 579 | 0.110 |
Why?
|
| DNA Damage | 1 | 2016 | 389 | 0.110 |
Why?
|
| Rabbits | 5 | 1999 | 618 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 253 | 0.110 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 84 | 0.110 |
Why?
|
| Dogs | 7 | 2011 | 634 | 0.100 |
Why?
|
| Hydroxyproline | 1 | 2014 | 11 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2010 | 79 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 94 | 0.100 |
Why?
|
| Receptor Cross-Talk | 2 | 2012 | 33 | 0.100 |
Why?
|
| Models, Biological | 5 | 2016 | 1768 | 0.100 |
Why?
|
| Pyroglyphidae | 1 | 2013 | 15 | 0.100 |
Why?
|
| Transcriptional Activation | 2 | 2006 | 290 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 308 | 0.100 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 1 | 2013 | 2 | 0.100 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2013 | 3 | 0.100 |
Why?
|
| Iloprost | 1 | 2013 | 14 | 0.100 |
Why?
|
| Colchicine | 1 | 2013 | 21 | 0.100 |
Why?
|
| Tubulin Modulators | 1 | 2013 | 23 | 0.100 |
Why?
|
| Amides | 1 | 2013 | 54 | 0.100 |
Why?
|
| Body Patterning | 1 | 2015 | 214 | 0.100 |
Why?
|
| Anilides | 1 | 2013 | 45 | 0.100 |
Why?
|
| Paclitaxel | 2 | 2013 | 479 | 0.100 |
Why?
|
| Response Elements | 2 | 2003 | 65 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2010 | 603 | 0.090 |
Why?
|
| Sumoylation | 1 | 2012 | 19 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2015 | 256 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2015 | 477 | 0.090 |
Why?
|
| Benzamides | 1 | 2013 | 246 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2012 | 78 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2013 | 1741 | 0.090 |
Why?
|
| Arginine | 1 | 2012 | 141 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 2755 | 0.090 |
Why?
|
| Zinc | 2 | 2002 | 99 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2015 | 713 | 0.090 |
Why?
|
| Protein Transport | 1 | 2013 | 438 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2011 | 555 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2011 | 39 | 0.090 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 83 | 0.090 |
Why?
|
| Hypertrophy | 2 | 2011 | 67 | 0.090 |
Why?
|
| Leukosialin | 1 | 2011 | 16 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 200 | 0.080 |
Why?
|
| Precipitin Tests | 3 | 2000 | 108 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 296 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2010 | 24 | 0.080 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 161 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2003 | 1914 | 0.080 |
Why?
|
| RNA Interference | 2 | 2015 | 379 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2012 | 246 | 0.080 |
Why?
|
| Autocrine Communication | 2 | 2007 | 20 | 0.080 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 3 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 1338 | 0.080 |
Why?
|
| Concanavalin A | 1 | 1989 | 46 | 0.080 |
Why?
|
| Male | 19 | 2019 | 44557 | 0.080 |
Why?
|
| Radiation-Protective Agents | 1 | 1990 | 98 | 0.080 |
Why?
|
| DNA Fragmentation | 3 | 2004 | 65 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 75 | 0.070 |
Why?
|
| Wound Healing | 1 | 2011 | 373 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 666 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 404 | 0.070 |
Why?
|
| Threonine | 2 | 2006 | 33 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2001 | 988 | 0.070 |
Why?
|
| Caspases | 4 | 2004 | 151 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2015 | 700 | 0.070 |
Why?
|
| COS Cells | 2 | 2006 | 164 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 254 | 0.070 |
Why?
|
| Smad4 Protein | 1 | 2008 | 26 | 0.070 |
Why?
|
| Receptors, Vasopressin | 2 | 1998 | 7 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 2012 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2004 | 52 | 0.070 |
Why?
|
| Histamine | 2 | 2003 | 116 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2005 | 66 | 0.070 |
Why?
|
| Cyclooxygenase 1 | 1 | 2007 | 5 | 0.070 |
Why?
|
| Time Factors | 6 | 2018 | 5410 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2007 | 69 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 2910 | 0.060 |
Why?
|
| Extracellular Space | 2 | 2004 | 88 | 0.060 |
Why?
|
| Casein Kinase I | 1 | 2006 | 2 | 0.060 |
Why?
|
| CREB-Binding Protein | 1 | 2006 | 16 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 68 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 122 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 353 | 0.060 |
Why?
|
| Phospholipases A2 | 3 | 2005 | 44 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2004 | 688 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 556 | 0.060 |
Why?
|
| Chlorine | 1 | 2005 | 8 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2002 | 55 | 0.060 |
Why?
|
| Rats, Inbred BN | 2 | 2002 | 37 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 1995 | 141 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2007 | 178 | 0.060 |
Why?
|
| Gene Library | 2 | 2002 | 126 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2003 | 282 | 0.060 |
Why?
|
| Kinetics | 4 | 2001 | 1492 | 0.060 |
Why?
|
| Dipeptides | 1 | 2004 | 39 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 2303 | 0.050 |
Why?
|
| Calcium Channels, L-Type | 1 | 2004 | 38 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 71 | 0.050 |
Why?
|
| NIH 3T3 Cells | 2 | 2018 | 111 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2011 | 272 | 0.050 |
Why?
|
| Nucleosomes | 1 | 2004 | 61 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 962 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2002 | 493 | 0.050 |
Why?
|
| Brain | 4 | 2022 | 2391 | 0.050 |
Why?
|
| Chemokines, CX3C | 1 | 2003 | 1 | 0.050 |
Why?
|
| Proline | 1 | 2003 | 49 | 0.050 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2003 | 12 | 0.050 |
Why?
|
| Rats, Inbred Strains | 3 | 2001 | 304 | 0.050 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 61 | 0.050 |
Why?
|
| Prion Proteins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 22 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 4 | 2004 | 25 | 0.050 |
Why?
|
| Elasticity | 1 | 2003 | 98 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Endothelium | 1 | 2002 | 59 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2007 | 2026 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2002 | 10 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2002 | 145 | 0.050 |
Why?
|
| Antigens | 1 | 2023 | 224 | 0.040 |
Why?
|
| Cholera Toxin | 1 | 2001 | 21 | 0.040 |
Why?
|
| Cytosol | 2 | 1999 | 193 | 0.040 |
Why?
|
| Leupeptins | 1 | 2001 | 21 | 0.040 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2001 | 38 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 2 | 1999 | 60 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1587 | 0.040 |
Why?
|
| Receptor, Endothelin A | 1 | 2001 | 21 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2015 | 248 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 61 | 0.040 |
Why?
|
| Heart Failure | 1 | 2011 | 1386 | 0.040 |
Why?
|
| Respiration | 1 | 2003 | 269 | 0.040 |
Why?
|
| Flavonoids | 1 | 2001 | 85 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 1173 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 88 | 0.040 |
Why?
|
| Guanylate Cyclase | 1 | 2000 | 19 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 110 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2011 | 43 | 0.040 |
Why?
|
| Pituitary Gland | 2 | 1998 | 116 | 0.040 |
Why?
|
| Nuclear Localization Signals | 1 | 2000 | 10 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2001 | 129 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2000 | 7 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2000 | 31 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2006 | 970 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2004 | 361 | 0.040 |
Why?
|
| Rats, Inbred SHR | 5 | 1991 | 33 | 0.040 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1999 | 24 | 0.040 |
Why?
|
| Biological Transport | 2 | 1999 | 404 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2000 | 209 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2000 | 139 | 0.040 |
Why?
|
| Type C Phospholipases | 2 | 1997 | 26 | 0.040 |
Why?
|
| Membrane Potentials | 4 | 2005 | 405 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2000 | 664 | 0.040 |
Why?
|
| Biomarkers | 2 | 2016 | 1910 | 0.040 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2019 | 12 | 0.040 |
Why?
|
| Receptors, Purinergic | 1 | 1999 | 7 | 0.040 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2019 | 16 | 0.040 |
Why?
|
| Son of Sevenless Proteins | 1 | 1998 | 2 | 0.040 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 1998 | 6 | 0.040 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1998 | 10 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 1999 | 66 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 94 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2004 | 546 | 0.040 |
Why?
|
| Caspase Inhibitors | 3 | 2004 | 32 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1998 | 39 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 1998 | 259 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 948 | 0.040 |
Why?
|
| Mutation | 2 | 2010 | 4272 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 19 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1998 | 17 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 1998 | 60 | 0.030 |
Why?
|
| Microorganisms, Genetically-Modified | 1 | 2018 | 1 | 0.030 |
Why?
|
| Receptors, Oxytocin | 1 | 1998 | 10 | 0.030 |
Why?
|
| Glycine | 1 | 2018 | 93 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 68 | 0.030 |
Why?
|
| Protein Kinases | 2 | 1988 | 210 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2016 | 21 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 28 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 376 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 302 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2016 | 51 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 98 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2016 | 74 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 251 | 0.030 |
Why?
|
| Opossums | 1 | 1995 | 5 | 0.030 |
Why?
|
| Nucleotides, Cyclic | 1 | 1995 | 12 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 1995 | 19 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 99 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 309 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 2010 | 291 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 187 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 696 | 0.030 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2015 | 14 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2015 | 25 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 32 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 436 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 98 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 11 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1994 | 25 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 186 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1994 | 32 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 50 | 0.030 |
Why?
|
| Astrocytes | 1 | 2015 | 141 | 0.030 |
Why?
|
| Losartan | 1 | 1994 | 29 | 0.030 |
Why?
|
| Tetrazoles | 1 | 1994 | 21 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2015 | 133 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 109 | 0.030 |
Why?
|
| Ligands | 2 | 2011 | 476 | 0.030 |
Why?
|
| Fibronectins | 1 | 2015 | 100 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1994 | 40 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 460 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 1994 | 60 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 133 | 0.030 |
Why?
|
| Mitochondria | 3 | 2004 | 612 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1931 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 159 | 0.030 |
Why?
|
| Female | 3 | 2015 | 48702 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 137 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 216 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 522 | 0.030 |
Why?
|
| Imidazoles | 1 | 1994 | 138 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 1028 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 502 | 0.030 |
Why?
|
| Epithelium | 1 | 1994 | 316 | 0.030 |
Why?
|
| Swine | 1 | 2015 | 588 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2000 | 1415 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2015 | 700 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 2004 | 84 | 0.020 |
Why?
|
| Insulin | 1 | 1998 | 1185 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1245 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 381 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2011 | 16 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 1775 | 0.020 |
Why?
|
| Immunological Synapses | 1 | 2011 | 5 | 0.020 |
Why?
|
| Protein Kinase C-theta | 1 | 2011 | 16 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 100 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2011 | 46 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Erythrocyte Membrane | 2 | 1988 | 61 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2011 | 52 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2002 | 192 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 148 | 0.020 |
Why?
|
| Colforsin | 2 | 2001 | 69 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 1866 | 0.020 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2011 | 87 | 0.020 |
Why?
|
| Caspase 3 | 2 | 2001 | 162 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 580 | 0.020 |
Why?
|
| Butadienes | 1 | 2010 | 33 | 0.020 |
Why?
|
| Hypertension, Renal | 1 | 1990 | 19 | 0.020 |
Why?
|
| RNA | 2 | 2007 | 573 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2010 | 61 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 1990 | 37 | 0.020 |
Why?
|
| Cyclic GMP | 2 | 2000 | 62 | 0.020 |
Why?
|
| Depsipeptides | 1 | 2010 | 29 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 2003 | 363 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 1989 | 19 | 0.020 |
Why?
|
| Fluorescence | 1 | 1989 | 100 | 0.020 |
Why?
|
| Nitriles | 1 | 2010 | 154 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 174 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 35 | 0.020 |
Why?
|
| Bronchoconstriction | 1 | 2008 | 49 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 570 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2002 | 1799 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 293 | 0.020 |
Why?
|
| Peptides | 2 | 2001 | 656 | 0.020 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1987 | 11 | 0.020 |
Why?
|
| Serum Response Element | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 409 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2008 | 113 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1762 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 526 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 572 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 398 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 824 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 2465 | 0.010 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2005 | 2 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2005 | 29 | 0.010 |
Why?
|
| Base Sequence | 2 | 2000 | 2220 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 1101 | 0.010 |
Why?
|
| Hypotonic Solutions | 1 | 2004 | 8 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 1004 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 2004 | 17 | 0.010 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2004 | 16 | 0.010 |
Why?
|
| Culture Media | 1 | 2004 | 139 | 0.010 |
Why?
|
| Intracellular Space | 1 | 2004 | 38 | 0.010 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2004 | 14 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 2004 | 27 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2004 | 300 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 121 | 0.010 |
Why?
|
| Receptors, HIV | 1 | 2003 | 2 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Thiocarbamates | 1 | 2003 | 6 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2003 | 6 | 0.010 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Chemokine CX3CL1 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2003 | 30 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 295 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 74 | 0.010 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2003 | 1 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 201 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 72 | 0.010 |
Why?
|
| Chemokine CXCL5 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Chemokine CXCL1 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 16 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 2002 | 12 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2002 | 5 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1922 | 0.010 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2002 | 7 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 422 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 76 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 273 | 0.010 |
Why?
|
| Ethylenediamines | 1 | 2001 | 14 | 0.010 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2001 | 2 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2001 | 32 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2001 | 47 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 2001 | 13 | 0.010 |
Why?
|
| Lanthanum | 2 | 1991 | 16 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 82 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 112 | 0.010 |
Why?
|
| fas Receptor | 1 | 2001 | 73 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 122 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2001 | 68 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 120 | 0.010 |
Why?
|
| Magnesium | 1 | 2001 | 173 | 0.010 |
Why?
|
| Receptors, Enterotoxin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 1 | 2000 | 1 | 0.010 |
Why?
|
| Wasp Venoms | 1 | 2000 | 3 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 278 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2000 | 111 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 141 | 0.010 |
Why?
|
| Plasmids | 1 | 2000 | 273 | 0.010 |
Why?
|
| Rubidium | 1 | 1999 | 9 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 248 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 587 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 249 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1999 | 19 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2001 | 515 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1990 | 122 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 1998 | 6 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1998 | 18 | 0.010 |
Why?
|
| Membranes | 1 | 1998 | 35 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 1998 | 56 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1998 | 75 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1997 | 25 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1997 | 31 | 0.010 |
Why?
|
| Tritium | 1 | 1997 | 116 | 0.010 |
Why?
|
| Thymidine | 1 | 1997 | 59 | 0.010 |
Why?
|
| Chromatin | 1 | 1999 | 440 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 436 | 0.010 |
Why?
|
| Calcimycin | 1 | 1991 | 32 | 0.010 |
Why?
|
| Nucleotides | 1 | 1991 | 93 | 0.010 |
Why?
|
| Ion Exchange | 1 | 1990 | 6 | 0.000 |
Why?
|
| Erythrocyte Volume | 1 | 1990 | 3 | 0.000 |
Why?
|
| Lithium | 1 | 1990 | 61 | 0.000 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1990 | 78 | 0.000 |
Why?
|
| Synaptosomes | 1 | 1989 | 14 | 0.000 |
Why?
|
| Middle Aged | 4 | 1990 | 27573 | 0.000 |
Why?
|
| Phosphatidylserines | 1 | 1988 | 21 | 0.000 |
Why?
|
| Bucladesine | 1 | 1988 | 12 | 0.000 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1988 | 82 | 0.000 |
Why?
|
| Oxidative Phosphorylation | 1 | 1987 | 58 | 0.000 |
Why?
|
| Adult | 3 | 1990 | 27918 | 0.000 |
Why?
|